DETERMINATION OF HLA-A,B RESIDUE MISMATCH ACCEPTABILITY FOR KIDNEYS TRANSPLANTED INTO HIGHLY SENSITIZED PATIENTS
Authors:
- 27 June 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 63 (12) , 1743-1751
Abstract
Background. During the 12th International Histocompatibility Workshop, a collaborative study between 35 laboratories was conducted on a group of highly allosensitized patients who had received a kidney transplant from 1981 to 1995. The major goal of the study was to assess how serum screening against a large cell panel could determine donor HLA mismatch acceptability in relation to graft outcome. Methods. Twenty laboratories participated in an extensive screening of 92 high panel-reactive antibody (PRA) sera from patients at 29 transplant centers worldwide; each patient had received a kidney allograft from an HLA-A,B mismatched unrelated donor. Screening was done by complement-dependent lymphocytotoxicity and antihuman globulin augmentation techniques using a common protocol and shared standardized reagents. After an extensive quality-control assessment, we selected data from 14 participants who had screened the sera against a combined panel of 535 HLA-typed cells. Results. With the 2×2 table-based Multiscreen computer program, we could readily determine for virtually every patient the significant correlations between serum reactivity and the presence of panel cell markers, including private and public HLA-A,B epitopes and amino acid residues assigned from published sequencing data. Donor mismatch acceptability was assessed at the amino acid residue level. In the complement-dependent lymphocytotoxicity (n=49; PRA=84.1±12.1%) and antihuman globulin (n=60; PRA=92.5±5.8%) groups, the 3-month graft survivals were 28% and 30% lower for unacceptable residue mismatches. Conclusions. These studies underscore the importance of a comprehensive serum screening analysis in the selection of appropriately mismatched donors for highly sensitized transplant patients.Keywords
This publication has 35 references indexed in Scilit:
- THE PREDICTIVE VALUE OF EPITOPE ANALYSIS IN HIGHLY SENSITIZED PATIENTS AWAITING RENAL TRANSPLANTATIONTransplantation, 1995
- Epitope specificity of HLA class I alloantibodies I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipientsHuman Immunology, 1994
- Structural diversity in the HLA‐A10 family of alleles: Correlations with serologyTissue Antigens, 1993
- MULTISCREEN SERUM ANALYSIS OF HIGHLY SENSITIZED RENAL DIALYSIS PATIENTS FOR ANTIBODIES TOWARD PUBLIC AND PRIVATE CLASS I HLA DETERMINANTSTransplantation, 1990
- Epitope map of the HLA-B7 CREG using affinity-purified human alloantibody probesHuman Immunology, 1990
- Topographic map of the HLA-A2 CREG epitopes using human alloantibody probesHuman Immunology, 1990
- STRUCTURE, FUNCTION, AND DIVERSITY OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULESAnnual Review of Biochemistry, 1990
- PRESENSITIZATION AND THE RENAL ALLOGRAFT RECIPIENTTransplantation, 1989
- PREIDCTION OF CROSSMATCH OUTCOME IN HIGHLY SENSITIZED DIALYSIS PATIENTS BASED ON THE IDENTIFICATION OF SERUM HLA ANTIBODIESTransplantation, 1986
- NEW APPROACHES TO DONOR CROSSMATCHING AND SUCCESSFUL TRANSPLANTATION OF HIGHLY SENSITIZED PATIENTS1,2Transplantation, 1983